GEN Exclusives

More »

GEN News Highlights

More »
Mar 11, 2008

Ace BioSciences Allies with PATH on Temperature-Stable Diarrhea Vaccines

  • Ace BioSciences will aid PATH in its efforts to create a vaccine against bacterial diarrhea for the developing world. The focus will be on developing temperature-stable ETEC (enterotoxigenic E. Coli) vaccine formulations.

    Funding for the research will come from PATH’s Enteric Vaccine Initiative. Ace Biosciences will collaborate with PATH’s Vaccine Stabilization Project team to develop dry and temperature-stable ETEC vaccine candidates.

    The pilot studies will use Ace BioSciences’ live, whole-cell oral vaccine candidate. ACE527, which the company is developing as a vaccine for traveller’s diarrhea, comprises three attenuated ETEC strains. Ace Biosciences reports that five Phase I trials have demonstrated safety and immunogenicity.


GEN Jobs powered by connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
More »

Be sure to take the GEN Poll

Disclosing Clinical Trial Data

Do you believe that conducting performance audits for new drugs will incentivize pharma firms to become more transparent?

More »